The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial

2019

Wissenschaftlicher Artikel

Hadji, Peyman

Stoetzer, Oliver

Decker, Thomas

Kurbacher, Christian M.

Marme, Frederik

et al.

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Journal of Bone Oncology ; 14 (2019). - Art.-Nr. UNSP 100199. - ISSN 2212-1374

DDC 610 / Medicine & health